Scottish Widows Investment Partnership logo

Scottish Widows Investment Partnership

Europe, Edinburgh, City of, United Kingdom, Edinburgh

Description

Scottish Widows Investment Partnership (SWIP) is one of Europe's largest asset management companies and part of the Lloyds Banking Group.

Investor Profile

Scottish Widows Investment Partnership has made 11 investments, with 1 in the past 12 months and 9% as lead.

Stage Focus

  • Series C (27%)
  • Series D (27%)
  • Debt Financing (9%)
  • Series E (9%)
  • Private Equity (9%)
  • Series B (9%)
  • Post Ipo Debt (9%)

Country Focus

  • United States (73%)
  • United Kingdom (18%)
  • Denmark (9%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Women's
  • Battery
  • Charging Infrastructure
  • Energy
  • Renewable Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Scottish Widows Investment Partnership frequently co-invest with?

Ascent Biomedical Ventures
North America, New York, United States, New York
Co-Investments: 3
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 6
MVM Life Science Partners
Europe, England, United Kingdom, London
Co-Investments: 2
BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 3
Saints Capital
North America, California, United States, San Francisco
Co-Investments: 2
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 4
JL
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Scottish Widows Investment Partnership?

Zenobe Energy

London, England, United Kingdom

Zenobe Energy manufactures battery storage assets for electric bus operators, utilities, and industrial and commercial businesses.

BatteryCharging InfrastructureEnergyRenewable Energy
Debt FinancingMay 29, 2024
Amount Raised: $520,607,816
The PRS REIT

Manchester, Manchester, United Kingdom

Investing in newly built private rented family housing

Financial ServicesReal EstateRentalVenture Capital
Post Ipo DebtAug 16, 2019
Amount Raised: $182,250,059
Radius Health

Cambridge, Massachusetts, United States

Radius Health develops drug therapies for osteoporosis and women’s health.

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalWomen's
Private EquityDec 16, 2011
Amount Raised: $21,400,000
Radius Health

Cambridge, Massachusetts, United States

Radius Health develops drug therapies for osteoporosis and women’s health.

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalWomen's
Series CJul 26, 2011
Amount Raised: $66,000,000
Cara Therapeutics

Shelton, Connecticut, United States

Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.

BiotechnologyHealth CareTherapeutics
Series DJul 21, 2010
Amount Raised: $15,000,000
Radius Health

Cambridge, Massachusetts, United States

Radius Health develops drug therapies for osteoporosis and women’s health.

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalWomen's
Series CNov 20, 2008
Amount Raised: $15,000,000
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series DJun 12, 2007
Amount Raised: $22,000,000
Radius Health

Cambridge, Massachusetts, United States

Radius Health develops drug therapies for osteoporosis and women’s health.

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalWomen's
Series BApr 2, 2007
Amount Raised: $57,500,000
Cara Therapeutics

Shelton, Connecticut, United States

Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.

BiotechnologyHealth CareTherapeutics
Series CNov 28, 2006
Amount Raised: $24,000,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series EFeb 10, 2006
Amount Raised: $30,400,000